MYO5A and PDE4B

  • Number of citations of the paper that reports this interaction (PubMedID 34039624)
  • 44
  • Data Source:
  • BioGRID (unspecified method)

MYO5A

PDE4B

Description myosin VA phosphodiesterase 4B
Image
GO Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Mean platelet volume ( 32888494)
  • Metabolite levels (Pyroglutamine) ( 23934736)
  • Acute lymphoblastic leukemia (childhood) ( 22076464 23007406)
  • Adult body size ( 32376654)
  • Age at first birth ( 34211149)
  • Age at first sexual intercourse ( 34211149)
  • Age at voice drop ( 27182965)
  • Alanine aminotransferase levels ( 33547301)
  • Alcohol consumption ( 31358974)
  • Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
  • Anxiety and stress-related disorders ( 31116379)
  • Anxiety and stress-related disorders (excluding adjustment disorder) ( 31116379)
  • Anxiety and stress-related disorders (excluding co-morbid schizophrenia) ( 31116379)
  • Anxiety and stress-related disorders (including obsessive-compulsive disorder) ( 31116379)
  • Anxiety and stress-related disorders (psychiatric co-morbidity covariate model) ( 31116379)
  • Anxiety and stress-related disorders (psychiatric co-morbidity weighting design) ( 31116379)
  • Anxiety disorders ( 31116379)
  • Aspartate aminotransferase levels ( 33547301)
  • Birth weight ( 31043758)
  • Body size at age 10 ( 32376654)
  • C-reactive protein levels ( 33339817)
  • Chronotype ( 30696823)
  • Echocardiographic traits ( 17903301)
  • Economic and political preferences (feminism/equality) ( 22566634)
  • Fibrinogen levels ( 28107422)
  • Gastroesophageal reflux disease ( 31527586)
  • Low tan response ( 29739929)
  • Multiple sclerosis ( 31604244)
  • Phenylephrine infusion rate during anesthesia ( 31455332)
  • Problematic alcohol use ( 32451486)
  • QT interval ( 29213071)
  • Risk-taking tendency (4-domain principal component model) ( 30643258)
  • Rosacea symptom severity ( 29771307)
  • Schizophrenia ( 30285260)
  • Sleep duration (short sleep) ( 30846698)
  • Smoking initiation ( 30617275 33082346)
  • Smoking initiation (ever regular vs never regular) ( 30679032)
  • Smoking status (ever vs never smokers) ( 30643258)
  • Staphylococcus aureus infection ( 24847357)
  • Stress-related disorders ( 31116379)
Interacting Genes 20 interacting genes: AKAP9 BMF CALM1 DLGAP1 DYNLL1 DYNLL2 ERG KIF5B MLPH NDEL1 NEFL PDE4B PRPH RAB11A RAB27A RAB3A RPH3A TRIM2 TRIM3 USP7 55 interacting genes: ACTN4 ANXA6 ARCN1 C11orf98 CALR CAPZA2 CDK11B CFL2 ENO1 FLNA FUS G3BP2 GSN H1-4 HBB HSPD1 IFRD1 IMMT KRT18 KRT6B LCP1 LYAR MAGEA11 MID1 MPRIP MSH2 MYH14 MYO1E MYO5A NONO OAT P4HB PDIA6 PKM PLOD1 PPIA PRKACA RCBTB2 RCN3 RIC8A RPL24 RPL35 RPL5 RPN2 RPS20 RPS4X RPS8 RPSA SMURF2 SND1 SSR3 TMEM41B TPM4 YWHAB YWHAQ
Entrez ID 4644 5142
HPRD ID 01179 02528
Ensembl ID ENSG00000197535 ENSG00000184588
Uniprot IDs A0A8I5KTF1 A0A8J8YWI7 A8CDT9 Q9UES4 Q9Y4I1 Q07343 Q59GM8 X5DNX5 X5DR82
PDB IDs 4D07 4J5L 4LLI 4LX1 4LX2 5JCY 5JCZ 1F0J 1RO6 1RO9 1ROR 1TB5 1XLX 1XLZ 1XM4 1XM6 1XMU 1XMY 1XN0 1XOS 1XOT 1Y2H 1Y2J 2CHM 2QYL 3D3P 3FRG 3G45 3GWT 3HC8 3HDZ 3HMV 3KKT 3LY2 3O0J 3O56 3O57 3W5E 3WD9 4KP6 4MYQ 4NW7 4WZI 4X0F 5K6J 5LAQ 5OHJ 6BOJ 8OEG
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?